Introduction

Alzheimer’s disease (AD) is a devastating neurodegenerative pathology that depreciates cognitive functions due to specific damage of brain areas involved in learning and memory including neocortex and the hippocampus (Braak and Braak 1991). Neuropathological features of AD brains include extracellular deposition of beta amyloid (Aβ) in the form of senile/neuritic plaques, intracellular neurofibrillary tangles (NFTs), synaptic loss and neuronal cell death (Selkoe 2002). Extracellular Aβ deposition triggers glial activation that is a common neuropathological feature of AD brains (Beach et al. 1989).

Originated from myelomonocytes, microglia are the resident immune-cells that enter the developing central nervous system (CNS) and undergo phenotypic metamorphosis to resting microglia, which detect and respond to both physiological and pathological changes in adult CNS homeostasis (van Rossum and Hanisch 2004; Kettenmann et al. 2011, 2013; Ransohoff and Perry 2009). In the healthy brain microglia are usually found in a “resting” state characterised by small somata and fine processes that continuously monitor their surroundings (Nimmerjahn et al. 2005). Pathology-induced alterations in CNS homeostasis trigger microglia remodelling, generally referred to microglial activation. Morphologically, this activation process is characterised by larger cell bodies and small/thicker processes (Kettenmann et al. 2011).

Regular physical activity and higher education level act as protective factors in preventing cognitive decline and reducing the risk of developing AD in the elderly population (Laurin et al. 2001; Wang et al. 2002). Exposure to voluntary wheel running (RUN) and enriched environment (ENR) in rodents had been designed to mimic the physical and cognitive “active” lifestyle in humans (Cracchiolo et al. 2007; Wood et al. 2010). These environments have profound effects on adult brain, which reacts to the increased physical activity and elevated complexity in the environmental condition. Exposure to RUN and ENR environments have been associated with improved memory performance and increased adult neurogenesis (Nilsson et al. 1999; Kempermann et al. 2002). In addition to their effect on hippocampal neurogenesis, exposure to RUN and ENR also induce profound effects on microglia (Steiner et al. 2004; Ehninger and Kempermann 2003; Ehninger et al. 2011). Although the early study by Altman and Das (1964) reported glial proliferation in rat cortex following exposure to ENR (Altman and Das 1964), more recent studies suggest region-specific alterations in microglia following exposure to RUN and ENR housing conditions (Ehninger and Kempermann 2003; Ehninger et al. 2011; Ziv et al. 2006).

Adult mice housed in RUN for 10 days showed an increase in the number of newly produced microglia (measured using Iba1 and BrdU staining) in the superficial layers of the cortex (Ehninger and Kempermann 2003). Similarly, exposure to ENR for 6 weeks triggered an increase in the number of resident isolectin B4 (IB-4)-positive microglia and newly produced microglia (measured using IB-4 and BrdU staining) in the rat hippocampus (Ziv et al. 2006). In contrast, more recent findings have shown that exposure to RUN (10 days) and ENR (40 days) reduced new-born microglia number in the amygdala of adult mice (Ehninger et al. 2011), suggesting regions-specificity of microglial alterations upon housing in RUN and ENR environments.

Environmental-induced changes in microglia using animal models of AD have been, hitherto, almost completely neglected. A single study in PS1ΔE9 and PS1M146L mouse models of AD revealed no changes in Iba1-positive microglia population in the hippocampus following exposure to ENR (1 h per day for 1 month) (Choi et al. 2008). The PS1ΔE9 and PS1M146L mouse models of AD, however, exhibit only partial AD-related neuropathology. Given the absence of studies in other mouse models of AD, environmental-induced changes in microglia response requires further clarification. In addition, no studies have addressed quantitative changes in microglia morphology following exposure to RUN and ENR in adult brains.

In the present study, we have investigated the effect of chronic (9 months) exposure to RUN and ENR on the numerical density (N v, #/mm3) and overall morphology of hippocampal microglia in the triple transgenic (3×Tg-AD) mouse model of AD, which expresses both Aβ plaques and NFTs with a spatiotemporal distribution that closely resembling AD pathology in humans; this model also exhibits age-related cognition deficits (Clinton et al. 2007; Oddo et al. 2003a, b; Frazer et al. 2008).

Materials and methods

All animal procedures were carried out in accordance with the United Kingdom Animals (Scientific Procedures) Act of 1986 under the license from the Home Office and were approved by the Animal Care and Ethical Committee at The University of Manchester (PCD 50/2506). All efforts were made to reduce the number of animals by following the 3Rs (reduction, refinement and replacement).

Animals and experimental design

The procedure for generating the triple transgenic (3×Tg-AD) mouse model of AD has been described in details previously (Oddo et al. 2003a, b; Rodríguez et al. 2008, 2009). Briefly, human cDNA harbouring the Swedish APP mutation (KM670/671NL) and human P301L four repeats mutated tau harbouring the P301L (tauP301L) mutations (both under control of the mouse Thy1.2 regulatory element) were co-microinjected into a single-cell embryo of a homozygous PS1M146V knock-in mouse (Oddo et al. 2003a, b). The background of the PS1 knock-in mice is a hybrid 129/C57BL6. The non-transgenic (non-Tg) control mice used were from the same strain and genetic background as the PS1 knock-in mice, but they express the endogenous wild-type mouse PS1 gene. All 3×Tg-AD and non-Tg control mice were obtained by crossing homozygous breeders. The animals were housed in the same-sex cage, kept in 12 h light–dark cycles with free access to food and water.

Following birth and weaning period (P21), the animals were housed in groups of at least four animals in standard laboratory environment until 3 months of age (Lafenetre et al. 2010; Rodríguez et al. 2011). Both 3×Tg-AD and non-Tg control mice were randomly assigned into control (STD, n = 5 for 3×Tg-AD and n = 4 non-Tg) housing, voluntary wheel running (RUN, n = 5 for 3×Tg-AD, n = 4 for non-Tg) or environmental enriched (ENR, n = 5 for both 3×Tg-AD and non-Tg) for period of 9 months (Fig. 1a) as previously considered and described (Catlow et al. 2009; Rodríguez et al. 2011; Wolf et al. 2006). The RUN group had free and unlimited access to a running wheel (Fig. 1b). The ENR housing was composed of coloured tunnels, climbing materials and a tilted running wheel (Fig. 1c). These mice were kept in the enrichment cages with the environment being regularly rearranged to maintain novelty (Cracchiolo et al. 2007), whilst the STD groups were kept in their respective standard cages. The animals were kept in STD, RUN and ENR environment for a period of 9 months, till they reached 12 months of age. We had chosen 12 months of age because our previous studies have shown that 3×Tg-AD animals displayed increase in both resting and activated microglial population in the hippocampus at this age (Rodríguez et al. 2010). In addition, we studied exclusively male mice to avoid the confounding effects of oestrous in female animals.

Fig. 1
figure 1

Experimental design. Following the weaning period (P21) male 3×Tg-AD and non-transgenic (Non-Tg) animals were housed in standard laboratory (STD) housing environment until 3 months of age. At 3 months of age animals were randomly assigned into either voluntary wheel running (RUN), environmental enriched (ENR) or STD condition for a period of 6 months a. The photographs show the set-up for RUN environment with a voluntary running wheel b and ENR environment containing coloured tunnels, climbing materials and tilted running wheels c. All animals were sacrificed by perfusion at 12 months of age. CTR standard housing cage, RUN large cage with unlimited access to a running wheel, ENR enriched cage

Fixation and tissue processing

Male 3×Tg-AD and their respective non-Tg control mice were anaesthetised with intraperitoneal injection of sodium pentobarbital. Mice were perfused through the aortic arch with 3.75 % acrolien (TAAB, UK) in a solution of 2 % paraformaldehyde (PFA, Sigma, UK) and 0.1 M phosphate buffer (PB) pH 7.4, followed by 2 % PFA. Brains were then removed and cut into 4–5 mm coronal slabs of tissue and were post-fixed in 2 % PFA for 24 h. Coronal sections of the brain were cut into 40–50 μm thick slices using a vibrating microtome (Leica, UK). Free floating brain sections were stored in cryoprotectant solution containing 25 % sucrose and 3.5 % glycerol in 0.05 M PB at pH 7.4. Coronal hemisections at levels −1.70 mm/−2.46 mm (hippocampus) posterior to bregma were selected for immunohistochemistry according to the mouse brain atlas of Paxinos and Franklin (2004).

Antibodies

A rabbit antiserum raised against the synthetic peptide corresponding to the C-terminus of ionised calcium binding adaptor 1 (Iba1, Wako, Germany) was used to identify microglial cells. To confirm that Iba1 antibody labels all microglial population in the hippocampus, we used Iba1 immunohistochemistry in the dorsal hippocampal section of CX3CR1+/eGFP mice, which selectively express Enhanced Green Fluorescent Protein in microglial cells (Fig. 2) (Jung et al. 2000; Srivastava et al. 2005). A polyclonal affinity-purified rat antiserum raised against CD11b (Mac-1, Serotec, UK) was used for the determination of activated microglial cells (Solovjov et al. 2005; Rodríguez et al. 2010).

Fig. 2
figure 2

Confocal micrographs showing the dorsal hippocampus of CX3CR1+/eGFP mice (a, d), Iba1-immunoreactive microglia (b, e) and their respective colocalisation (c, f). Note that Iba1-positive microglia stains all microglia population in the dorsal hippocampus. Scale bars ac = 200 μm, df = 20 μm

Finally, for the identification of Aβ plaques a monoclonal mouse antibody against the amino acid residues 1–16 of Aβ (Covance, USA) was used. The specificity of these antibodies has been reported previously using immunohistochemistry (Noristani et al. 2010; Rodríguez et al. 2010; Olabarria et al. 2011; Yoshikawa et al. 2010) and western blot analysis (Yang et al. 2010). To assess for non-specific background labelling or cross reactivity between antibodies derived from different host species, a series of control experiments were performed. Omission of primary and/or secondary antibodies from the incubation solutions resulted in a total absence of target labelling.

Immunohistochemistry

Brain sections were incubated for 30 min in 30 % methanol and 3 % hydrogen peroxide (H2O2, Sigma, UK) in 0.1 M PB followed by 0.1 M PB (5 min) and 1 % sodium borohydride (Aldrich, UK, 30 min). Sections were washed with 0.1 M PB profusely and placed in 0.1 M trizma base saline (TS, 10 min) followed by incubation in 0.5 % albumin bovine serum (BSA, Sigma, UK) in 0.1 M TS and 0.25 % Triton (Sigma, UK) for 30 min and 48 h incubation in rabbit anti-Iba1 (1:2,000) primary antibody. The sections were rinsed in 0.1 M TS for 30 min and incubated in 1:200 dilution of Alexa 488 goat anti-rabbit (Invitrogen, UK) IgG, secondary antibody for 1 h at followed by rinsing in 0.1 M TS.

For the dual peroxidase labelling sections were incubated for 48 h in both primary antibodies cocktail (1) rabbit anti-Iba1 (1:2,000) and (2) mouse anti-beta amyloid monoclonal antibody (1:2,000) simultaneously. The Iba1 and Aβ antibodies were detected in a sequential manner on the same sections. For Iba1 labelling, the sections were incubated in 1:200 dilutions of biotinylated donkey anti-rabbit IgG (Jackson Immunoresearch, UK) for 1 h followed by incubation for 30 min in avidin–biotin peroxidase complex (ABC, Vector Laboratories Ltd., UK). The peroxidase reaction product was visualised by incubation in a solution containing 0.022 % of 3,3′diaminobenzidine (Aldrich, UK) and 0.003 % H2O2. For Aβ labelling, the same brains sections were incubated in 1:200 dilution of biotinylated horse anti-mouse IgG followed by incubation for 30 min in ABC. The Aβ peroxidase reaction was visualised by incubation in SGZ kit (Vector Laboratories Ltd., UK) as described previously (Rodríguez et al. 2008, 2011). This allowed us to see the Iba1 labelling in brown, thus differentiating it from the Aβ neuritic plaques labelled in blue as they were visualised and revealed by a SGZ kit.

For triple immunofluorescence labelling, the sections were incubated for 48 h at room temperature in primary antibody cocktail (1) rabbit anti-Iba1 (1:2,000), (2) mouse anti-Aβ (1:2,000) and (3) rat anti-Mac-1 (1:1,000) simultaneously. Subsequently, each antigen was detected in a sequential manner on the same sections by incubation with Alexa 595 goat anti-mouse, Alexa 488 goat anti-rabbit and Alexa 633 goat anti-rat (Invitrogen, UK). Finally, sections were rinsed with 0.1 M PB for 30 min and permanently mounted in an aqueous medium.

Quantification of Iba1 positive microglia

The numerical density (N v, #/mm3) of Iba1-positive microglia were analysed in the CA1 subfield of the hippocampus. We used five representative non-consecutive sections throughout the dorsal hippocampus (analysed in an area of 235,000 μm2 for CA1 in coronal sections of 40 μm thickness). To ensure unbiased microglial counting, representative sections were selected in random, taken into account that they represented similar anatomical level of the hippocampus and its individual layers. The specific analysed areas were the stratum oriens (S.Or), the stratum radiatum (S.Rad) and the stratum lacunosum moleculare (S.Mol) of the hippocampal CA1 subfield. Confocal stack images were used for this propose. Hippocampal boundaries were clearly delineated, thus, counts were reproducible. Iba1-positive microglia cells were intensely labelled against dark background that made them easy to identify with equal chance of being counted. All counting of Iba1-positive microglia cells were conducted by a single investigator (H.N.N) who was blind to the mice genotype and housing environments, therefore, counting bias was kept to a minimum.

Optical density (OD) measurement

Using computer-assisted imaging analysis (ImageJ 1.32j, NIH, Bethesda, MD, USA), we analysed the density of intraneuronal Aβ by measuring their optical density (OD), as we have described previously (Noristani et al. 2010). In brief and to exclude any experimental errors and/or bias, all images were taken at a constant light intensity. The OD was calculated from a relative scale of intensity ranging from 0 to 255, with a measurement of 255 corresponding to the area with very low intraneuronal Aβ accumulation and 0 corresponding to the densest area of labelling (Noristani et al. 2010). The calibration density was kept constant for measuring all section to avoid experimental variances. Non-specific OD in sections was measured from the corpus callosum. The density of intraneuronal Aβ was measured in stratum pyramidale (PCL), of CA1, CA2 and CA3 subfields of the hippocampus in the 3×Tg-AD mouse model of AD at 12 months of age following chronic exposure to STD, RUN and ENR housing. To analyse the changes in intraneuronal Aβ against constant control, 255 was divided by the control region (corpus callosum) and the obtained factor was multiplied by the region of interest in every given section (Noristani et al. 2010). Inverse optical density was obtained by subtracting from the obtained background level (255). Measurement of mean density were taken and averaged, after background subtraction, from each hippocampal layers in both the left and the right hemisphere of each slice. The results are shown as inverse optical density (IOD/pixel).

Morphological analysis of microglial domain

Microglia (n = 30–35) were imaged using confocal scanning microscopy (Olympus, inverted), recording layers at every 0.6 μm. Parallel confocal planes were superimposed and morphological analysis was carried out by cell analyst programme (Chvatal et al. 2007) using digital filters (average 3 × 3, convolution, gauss 5 × 5, despeckle, simple objects removal) to determine the surface (S) and the volume (V) of Iba1-immunostained microglia, as previously described (Olabarria et al. 2010; Yeh et al. 2011).

Statistical analysis

Data are expressed as mean ± standard error of the mean (SEM). Unpaired t tests were used to examine differences in the N v, surface and volume of Iba1 labelled microglia between the 3×Tg-AD and non-Tg control animals in different housing environment. Significance was accepted at p ≤ 0.05. The data were analysed using GraphPad Prism 4.0 (GraphPad Software, Inc.).

Results

Heterogeneous distribution of microglial cells in different layers of hippocampus

In the CA1 subfield of both non-Tg control and 3×Tg-AD mice the density of Iba1-positive microglia varied between hippocampal layers (Fig. 3). The highest density of Iba1-positive microglia was found in the stratum lacunosum moleculare (S. Mol) of CA1 subfield compared to other hippocampal strata (on average 11,363 in 3×Tg-AD and 10,777 Iba1-positive cells/mm3 in non-Tg control, Fig. 3a–f). The stratum oriens (S.Or) and the stratum radiatum (S.Rad) have less microglia (on average 8,011 in 3×Tg-AD and 8,457 Iba1-positive cells/mm3 in non-Tg control within S.Or and 8,025 in 3×Tg-AD and 8,120 Iba1-positive cells/mm3 in non-Tg control within S.Rad), whereas Iba1-positive microglia was rarely observed in the stratum pyramidale of the hippocampus. This difference in distribution of microglia within different hippocampal layers was observed irrespective of genotype and housing environment (Fig. 3).

Fig. 3
figure 3

Confocal micrographs showing Iba1-immunoreactive microglia in the dorsal hippocampus of non-Tg (ac) and 3×Tg-AD (df) mice housed in STD (a, d), RUN (b, e) and ENR (c, f) environments. Scale bars af = 100 μm, a′–f′ = 50 μm

Morphologically, we classified microglial cells into two groups: (i) resting microglia displayed small cell bodies equipped with thin to-medium ramified processes extending to the surrounding neuropil, and (ii) activated microglia characterised by enlarged cell bodies with short and thick processes (Fig. 3a–f).

3×Tg-AD mice in STD environment displayed increased numerical density of microglia in CA1 S. Mol

Global analysis of CA1 subfield (all stratas combined) showed no general changes in Iba1-positive microglia cells in the CA1 subfield of the hippocampus between 3×Tg-AD and non-Tg control mice housed in either in STD, RUN and ENR environments (p = 0.3085, Fig. 4a). However, a detailed quantitative analysis of individual CA1 layers revealed that 3×Tg-AD mice housed in STD condition displayed increased N v of Iba1-positive microglia compared to non-Tg group in the CA1 S.Mol (11.7 % increase, p = 0.0183, Fig. 4d), which also exhibited the highest density of microglial density in both 3×Tg-AD and non-Tg control groups. No changes were observed in microglial density between 3×Tg-AD and non-Tg control housed in RUN and ENR environments (Fig. 4d). Similarly, CA1 S.Or and CA1 S.Rad showed no changes in microglial density between 3×Tg-AD and non-Tg control mice housed in STD, RUN or ENR housing environments (p = 0.5503 for S.Or, p = 0.9062 for S.Rad, Fig. 4b, respectively).

Fig. 4
figure 4

Bar graphs showing the effect of RUN and ENR environment on the N v of Iba1-positive microglia in the different strata of the CA1 subfield of hippocampus a. Bars represent mean ± SEM, *p < 0.05, **p < 0.01 compared to 3×Tg-AD animals in the STD housing environment, # p < 0.05 compared to non-Tg in the same housing environment

ENR environment decreased microglial numerical density in CA1 region in 3×Tg-AD mice

3×Tg-AD mice housed in ENR environment showed significantly reduced numerical density of Iba1-positive microglia in the CA1 subfield of the hippocampus compared to 3×Tg-AD group housed in STD housing environment (9.3 % decrease, p = 0.0077, Fig. 4a). Analysis of individual CA1 strata revealed that ENR-induced decrease in Iba1-positive microglia was significant in the CA1 S.Or (11.5 % decrease, p = 0.0162, Fig. 4b) and CA1 S.Mol (7.6 % decrease, p = 0.0335, Fig. 4d), but not in CA1 S.Rad (7.3 % decrease, p = 0.1131, Fig. 4c). No environmental-induced changes were observed in non-Tg control group neither in CA1 subfield nor in other hippocampal strata (Fig. 4).

RUN environment potentiated microglial activation in 3×Tg-AD animals

To determine whether environmental stimulation affects microglial morphology we analysed the surface (μm2), volume (μm3) and somata volume (μm3) of Iba1-positive microglia in 3×Tg-AD mice exposed to STD, RUN and ENR housing environments (Fig. 5). Since no changes were observed in the N v of microglia in non-Tg control animals, the latter group was not included in morphological analysis. Iba1-positive microglia in 3×Tg-AD mice exposed to RUN environment showed a significant increase in surface (61 %, p = 0.0217, Fig. 5b, d) and volume (78 %, p = 0.0104, Fig. 5b, e) when compared to 3×Tg-AD animals in STD environment. RUN-induced increase in microglia surface and volume was also accompanied by a significant increase in somata volume (41 %, p = 0.0098, Fig. 5b, f). No significant differences were observed in microglial surface, volume and somata volume in 3×Tg-AD animals exposed to ENR environment when compared to STD group.

Fig. 5
figure 5

Confocal micrographs showing environmental-induced changes in microglial morphology in 3×Tg-AD mice housed in STD a, RUN b and ENR c environments. Scale bars ac = 20 μm. Bar graphs showing environmental-induced changes in microglial surface d, volume e and somata volume f in the 3×Tg-AD mouse model of AD. Bars represent mean ± SEM, *p < 0.05, **p < 0.01 compared to 3×Tg-AD animals in the STD housing environment

Environmental-induced alterations in microglia is independent of Aβ neuropathology in 3×Tg-AD animals

To examine whether RUN and ENR-induced alteration in microglia is driven by Aβ neuropathology, we studied Aβ neuropathology in 3×Tg-AD mice housed in RUN and ENR compared to that of STD housing at 12 months of age. Our immunohistochemical analysis showed pronounced intraneuronal Aβ deposition with rate Aβ neuritic plaques at 12 months of age in 3×Tg-AD mice housed in RUN, ENR and STD environments. Our quantitative analysis of intraneuronal Aβ density showed no changes in 3×Tg-AD animals upon exposure to RUN or ENR compared to that STD housing condition (supplementary Fig. 1).

Increased Aβ deposition was clearly evident at 18-month-old 3×Tg-AD mice. Dual peroxidase labelling revealed high density of Aβ neuritic plaques in the CA1 subfield of the hippocampus that was mainly surrounded by activated Iba1-positive microglia in the 3×Tg-AD mouse model of AD at 18 months of age (Fig. 6a, b). Iba1-positive microglial cells located distal to Aβ plaques, showed typical ramified features including small cell body with large/thin ramified processes (Fig. 6c).

Fig. 6
figure 6

Brightfield micrographs showing Iba1 and Aβ immunoreactivity in the dorsal hippocampus of 3×Tg-AD mice a with both amoeboid b and ramified c Iba1-positive microglia. Scale bars a = 100 μm, b, c = 20 μm

Triple immunofluorescence labelling revealed high density of Iba1 and Mac-1 positive microglia, adjacent to Aβ plaques and Aβ aggregates. In particular, triple labelling showed Aβ aggregate engulfment inside activated microglial somata that was characterised by Iba1 and Mac-1 staining (Fig. 7).

Fig. 7
figure 7

Confocal micrographs showing amoeboid microglia characterised by Iba1 a and MAC-1 b labelling that is actively taking up Aβ c in microglia somata. Scale bars ad = 10 μm

Discussion

The major finding from the current study is that 3×Tg-AD mouse model of AD, housed in standard (STD) housing environment, displays strata-specific increase in microglial numerical density (N v, #/mm3) in CA1 S.Mol that was reversed following chronic exposure to running (RUN) and enriched (ENR) housing environments. In particular, RUN and ENR significantly reduced microglia N v in 3×Tg-AD mice compared to their counterparts housed in STD environment. Furthermore, 3×Tg-AD mice house in RUN, but not ENR, displayed pronounced microglial hypertrophy compared to 3×Tg-AD mice housed in STD environment. Interestingly, intraneuronal Aβ density remained stable in both RUN and ENR housing conditions suggesting that environmental-induced changes in microglia are independent of amyloid pathology in 3×Tg-AD mouse model of the disease.

Increased microglial density in the 3×Tg-AD mouse model of AD

Our finding of increased microglial N v in CA1 S.Mol of 3×Tg-AD mice housed in STD environment (Fig. 4d), is in agreement with our previous report where we found an increased density of both ramified and activated microglia in the CA1 subfield of the hippocampus at 12 months of age (Rodríguez et al. 2010). Other studies, including our recent findings, suggest that increased microglia density in 3×Tg-AD mice closely resembles the evolution of AD-related neuropathology with the earliest increase in microglial density occurring in the entorhinal cortex [6 months, (Janelsins et al. 2005)] followed by the CA1 subfield [9–12 months, (Rodríguez et al. 2013)] and the dentate gyrus [DG, 18 months, (Rodríguez et al. 2013)] of the hippocampus. Post-mortem AD brains also showed a specific spatiotemporal evolution of AD-related neuropathology, with the initial degenerative signs appearing in entorhinal cortex that is then spread towards the hippocampus and other cortical areas (Van Hoesen and Hyman 1990; Braak and Braak 1991; Ohm 2007).

AD-associated increase in microglia density has been consistently reported in post-mortem AD brains (McGeer et al. 1987) and in numerous transgenic mouse models of AD with excessive Aβ neuropathology namely: APPswe (Frautschy et al. 1998), PS1×APP, (Jimenez et al. 2008) and APPswe/PS1d9×YFP mice (Meyer-Luehmann et al. 2008).

Although the triggering mechanism for AD-related increase in microglial density is not currently known, it is likely to be due to amyloidogenic accumulation of not only Aβ neuritic plaques but also smaller Aβ aggregates (Rodríguez et al. 2010; Matsuoka et al. 2001). Previous studies have shown that hippocampal Aβ plaque formation is initiated between 9 and 12 months and becomes more evident at 18 months and older age in 3×Tg-AD mice (Oddo et al. 2003a, b; Rodríguez et al. 2008). The initiation of extracellular Aβ aggregates in 3×Tg-AD mice directly correlates with increased microglial density in this brain region (Rodríguez et al. 2010).

Activated microglia accumulates around Aβ plaques. Dual peroxidase labelling revealed that Aβ plaques are surrounded by Iba1-positive microglia that display different morphological features depending on their vicinity to Aβ plaques (Fig. 6). Specifically, microglia located adjacent to Aβ plaques displayed activated status as revealed by an increase in their soma and appearance of thicker processes (Fig. 6b), whilst microglia located at a distance from Aβ plaques showed typical ramified features including small soma with thin/medium ramified processes (Fig. 6c). Triple florescence labelling revealed that activated microglia (characterised by Iba1 and Mac-1 immunostaining) are actively involved in the uptake of Aβ aggregate inside microglial somata (Fig. 7). Given the close association between Aβ aggregation and increased microglial density, it is likely that Aβ deposition may act as an underlying mechanism for stimulating increased microglial density in 3×Tg-AD mice.

Exposure to ENR environment reduces microglia population in the 3×Tg-AD mouse model of AD independent of Aβ neuropathology

The finding of ENR-induced decrease in hippocampal microglia population (Fig. 4) is contradictory to a previous report in PS1ΔE9 and PS1M146L mice, which showed no changes in Iba1-positive hippocampal microglia following exposure to ENR (Choi et al. 2008). Multiple factors may account for contradictory findings including (i) experimental designs, (ii) transgenic line and (iii) the age of the transgenic mice.

Specifically, Choi et al. (2008) exposed PS1ΔE9 and PS1M146L mice in ENR 1 h per day for a period of 1 month as opposed to the current study where the 3×Tg-AD mice were continuously housed in ENR for 9 months (see “Materials and methods”). In addition, PS1ΔE9 and PS1M146L mice only express Aβ plaques, with no evident NFT neuropathology as opposed to 3×Tg-AD mice, which expressed both Aβ plaques and NFTs that closely resembles AD evolution in humans (Oddo et al. 2003a, b). Furthermore, Choi et al. (2008) investigated environmental-induced alterations in microglia proliferation in young (2 months) mice compared to 12 months of age in the current study. As mentioned previously, we had chosen this age because our previous report had shown increased density of both ramified and activated microglia in 3×Tg-AD mice at 12 months (Rodríguez et al. 2010). Given the age-specific increase in microglial density in different brain regions in the 3×Tg-AD mice (discussed above), differences in examined age may significantly contribute to the contradictory findings between the two studies.

Although, to our knowledge, there are no other reports on environmental-induced alterations in microglia population using transgenic models of AD, studies in wild-type mice and rats suggest region-specific changes in microglia following exposure to RUN and ENR housing (Ehninger and Kempermann 2003; Ehninger et al. 2011; Ziv et al. 2006). Exposure to RUN and ENR increased microglial proliferation in the mice cortex (Ehninger and Kempermann 2003) and the rat hippocampus (Ziv et al. 2006), while reducing the number of new-born microglia in the mice amygdala (Ehninger et al. 2011).

Unlike ENR, exposure to RUN had no significant effect in reducing hippocampal microglial N v in 3×Tg-AD mice (Fig. 4). Such ENR-induced decrease in microglial N v may be due to the “complete” enriched environment that includes not only increased physical activity but also increased social/cognitive stimulation compared to that of RUN (Cracchiolo et al. 2007). Each of the above factors may have a synergistic effect on microglial N v over and above achieved by increased physical activity in RUN environment (van Praag et al. 2000).

Exposure to RUN environment potentiates activation of microglia in the 3×Tg-AD mouse model of AD

The increase microglial hypertrophy following exposure to RUN environment is, to our knowledge, the first quantitative report on environmental-induced alteration on microglial morphology in a transgenic mouse model of AD (Fig. 5). Similarly, although previous studies have reported both increased and reduced microglial proliferation in rodents following exposure to RUN and ENR environments (Ehninger and Kempermann 2003; Ehninger et al. 2011; Ziv et al. 2006), no study has investigated microglia hypertrophy via quantitative analysis of microglia morphology. Interestingly, Ehninger and Kempermann (2003) reported no qualitative morphological changes in cortical microglia of adult mice following exposure to RUN environment (Ehninger and Kempermann 2003).

RUN-induced alterations in microglia morphology in 3×Tg-AD mice suggest that these glia cells plastically react to physiological stimuli such as exposure to RUN and ENR environments. Although the functional significance of RUN-dependent microglia hypertrophy remains ambiguous, previous reports have shown close association between increased microglial activation and adult neurogenesis (Ziv et al. 2006).

Previous studies in our laboratory have reported impaired adult neurogenesis in 3×Tg-AD mice both in the dentate gyrus (Rodríguez et al. 2008) and the subventricular zone (Rodríguez et al. 2009), which was reversed following exposure to RUN and ENR environment (Rodríguez et al. 2011). Given the fact that activation of microglia promote neurogenesis both in vitro (Butovsky et al. 2006) and in vivo (Ziv et al. 2006), our results suggest that RUN-induced increased in microglia activation may participate in re-storing the impaired neurogenesis in the 3×Tg-AD mouse model of AD (Rodríguez et al. 2011).

RUN and ENR environments have no effect on Aβ pathology in 3×Tg-AD animals

Neither RUN nor ENR altered intraneuronal Aβ deposition compared to that of the STD housing in 3×Tg-AD mice (supplementary Fig. 1). These finding suggest that environmental-induced changes in microglia is independent of amyloid pathology in 3×Tg-AD mice. These findings are in agreement with Arendash et al. (2004) who also reported no changes in brain Aβ deposition in aged APPswe transgenic mice following chronic (4 months) exposure to RUN and ENR environments (Arendash et al. 2004). In addition, Wolf et al. (2006) showed stable Aβ plaque load using three different techniques (area fraction fractionator, surface area and absolute number of Aβ plaques) in the cortex and the hippocampus of 16-month-old APP23 mice upon chronic (11 months) exposure to RUN and ENR housing environment (Wolf et al. 2006). Finally, these findings are supported by Mirochnic et al. (2009) who also showed that neither RUN nor ENR housing altered the fraction of the hippocampus covered by Aβ plaques at 18 months in APP23 transgenic mice (Mirochnic et al. 2009).

Contrary, others have shown that both RUN and ENR reduces Aβ load in multiple transgenic mouse models of AD including APPswe/PS1 (Cracchiolo et al. 2007) (decreased Aβ deposition), PS1/PdAPP (Costa et al. 2007) (showed 50 % less brain beta-amyloid) and TgCRND8 transgenic mice (Adlard et al. 2005). As mentioned above, these contradictory findings may be due to differences in the experimental designs, transgenic line and the examined age of the transgenic mice.

In summary, our results indicate that RUN and ENR environment have differential effects on microglia cell density/and morphology. Specifically, whilst exposure to ENR environment reduced microglia N v, increased physical activity induced microglia hypertrophy as evident by increase in microglia surface, volume and somata volume. Such microglia activation in the 3×Tg-AD mouse model of AD highlights their involvement not only due to disease-related state, but also following physiological stimuli.